Suppr超能文献

静脉注射奥美拉唑对消化性溃疡出血患者内镜治疗成功后胃内pH值及预后的影响——一项前瞻性随机对照试验。

The influence of intravenous omeprazole on intragastric pH and outcomes in patients with peptic ulcer bleeding after successful endoscopic therapy--a prospective randomized comparative trial.

作者信息

Tseng G Y, Lin H J, Lin H Y, Perng C L, Lee F Y, Lo W C, Chang F Y, Lee S D

机构信息

Department of Medicine, VGH-TAIPEI, Taiwan.

出版信息

Hepatogastroenterology. 1999 Jul-Aug;46(28):2183-8.

Abstract

BACKGROUND/AIMS: The role of omeprazole in preventing rebleeding in patients with peptic ulcer bleeding after successful endoscopic therapy has been controversial. In this study, we used 3 different formulas of intravenous omeprazole in the above patients. We wished to compare the intragastric pH and outcomes among them.

METHODOLOGY

Between July 1996 and May 1997, after having obtained initial hemostasis with endoscopic therapy, a total of 20 patients with peptic ulcer bleeding (spurting/oozing/non-bleeding visible vessel: 6/4/10) received intravenous bolus of omeprazole 20 mg every 3 hours; 20 patients (3/5/12) received intravenous bolus of omeprazole 40 mg every 6 hours; and, 20 patients (5/4/11) received intravenous bolus of omeprazole 80 mg every 12 hours for 3 days. One intragastric pH meter (Gastrograph Mark III, Medical Instruments Corp. Switzerland) was used to record 24-hour intragastic pH.

RESULTS

The intragastric pH in the patients receiving omeprazole 20 mg every 3 hours was 6.1, 6.0-6.2 (mean: 95% CI); in patients receiving omeprazole 40 mg every 6 hours it was 6.4, 6.2-6.5; and, in patients receiving omeprazole 80 mg every 12 hours it was 5.8, 5.7-5.9. The duration of intragastric pH > 6.0 in omeprazole 20 mg every 3 hours was 70.9%, 57.3%-84.4% (mean: 95% CI); in omeprazole 40 mg every 6 hours it was 83.1%, 73.1%-93.1%; and, in omeprazole 80 mg every 12 hours it was 66%, 51.5%-80.4%. Patients with peptic ulcers receiving omeprazole 40 mg intravenous bolus every 6 hours had the highest intragastric pH as compared with the other 2 groups (p < 0.0001). There were no significant differences concerning rebleeding rates, volume of blood transfusion, hospital stay, numbers of operation and mortality among the 3 groups.

CONCLUSIONS

After initial hemostasis had been obtained, patients with peptic ulcer bleeding receiving 40 mg intravenous bolus every 6 hours had the highest intragastric pH. However, they had similar outcomes with the other 2 groups.

摘要

背景/目的:奥美拉唑在成功内镜治疗后预防消化性溃疡出血患者再出血中的作用一直存在争议。在本研究中,我们对上述患者使用了3种不同配方的静脉注射用奥美拉唑。我们希望比较它们之间的胃内pH值及治疗结果。

方法

1996年7月至1997年5月期间,在内镜治疗实现初步止血后,共有20例消化性溃疡出血患者(喷射性出血/渗血/可见非出血血管:6/4/10)每3小时静脉推注20mg奥美拉唑;20例患者(3/5/12)每6小时静脉推注40mg奥美拉唑;20例患者(5/4/11)每12小时静脉推注80mg奥美拉唑,持续3天。使用一台胃内pH计(Gastrograph Mark III,瑞士医疗器械公司)记录24小时胃内pH值。

结果

每3小时接受20mg奥美拉唑治疗的患者胃内pH值为6.1,6.0 - 6.2(均值:95%可信区间);每6小时接受40mg奥美拉唑治疗的患者胃内pH值为6.4,6.2 - 6.5;每12小时接受80mg奥美拉唑治疗的患者胃内pH值为5.8,5.7 - 5.9。每3小时接受20mg奥美拉唑治疗的患者胃内pH值>6.0的持续时间为70.9%,57.3% - 84.4%(均值:95%可信区间);每6小时接受40mg奥美拉唑治疗的患者为83.1%,73.1% - 93.1%;每12小时接受80mg奥美拉唑治疗的患者为66%,51.5% - 80.4%。与其他两组相比,每6小时静脉推注40mg奥美拉唑的消化性溃疡患者胃内pH值最高(p < 0.0001)。三组在再出血率、输血量、住院时间、手术例数和死亡率方面无显著差异。

结论

在实现初步止血后,每6小时静脉推注40mg奥美拉唑的消化性溃疡出血患者胃内pH值最高。然而,他们与其他两组的治疗结果相似。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验